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Progressive familial intrahepatic cholestasis (PFIC) is a rare heterogeneous autosomal recessive disease with an estimated incidence of about 1/50,000-1/100,000 
births [1]. There are three types recognized. Type 2 known as 
bile salt export pump (BSEP) deficiency involves ABCB11 
gene mutation leading to BSEP defect causing accumulation of 
bile salts within canaliculi and eventually, hepatocellular injury. 
It typically presents during infancy or early childhood with 
intractable pruritus, jaundice, failure to thrive, and normal-to-low 
levels of gamma glutamyl transferase (GGT). Histology reveals 
canalicular and ductular cholestasis, with minimal inflammation; 
later, progressing to micronodular or biliary cirrhosis. The first 
line of treatment is medical management aimed at controlling 
pruritus along with supportive care. Surgical options include 
partial internal biliary diversion in non-cirrhotic low GGT PFIC 
with intractable pruritus [2]. Liver transplantation is indicated 
in decompensated cirrhosis or in cases of failed diversion with 
debilitating pruritus.
CASE REPORTS
Case 1
A 10-month-old male child born of non-consanguineous marriage 
with uneventful antenatal and post-natal course was admitted 
with complaints of fever for 5 days, 15 days before admission. 
Fever was followed by yellowish discoloration of eyes and urine 
for 10 days with one episode of melena for which he received 
transfusion outside. There was no history of abdominal distension, 
pruritus, irritability, poor feeding, clay-colored stools, diarrhea, 
or steatorrhea and no history of jaundice, blood transfusion, or 
hospital admission in the past.
Child was hemodynamically stable at admission with normal 
growth pattern. On examination, pallor, icterus, and conjunctival 
xerosis were present. There was no facial dysmorphism or signs 
of liver cell failure. His abdomen was distended with firm and 
enlarged liver (span 11 cm) with splenomegaly of 3 cm below 
the costal margin. There was no free fluid. Other systemic 
examination was normal.
Complete hemogram was suggestive of microcytic 
hypochromic anemia with neutrophilia leukocytosis and normal 
platelet count. He had total bilirubin of 13.4 mg/dl with direct 
fraction of 7.4 mg/dl, aminotransferase/AST- 70/283 IU, and 
international normalized ratio (INR) of 1.4. GGT was 55 IU. 
We ruled out viral hepatitis, leptospirosis, and infectious 
mononucleosis. There was evidence of culture positive urinary 
tract infection (Escherichia coli) which was treated with 
appropriate antibiotics. Metabolic workup, fundus, and G-6PD 
were normal. Abdominal ultrasonography showed a normal 
hepatic echotexture and biliary system without any focal lesion. 
Portal vein size was normal with normal flow seen in portocaval 
vessels. The patient was treated with antibiotics and vitamin 
supplements.
During hospital stay, his fever subsided without any features 
of decompensation. Liver biopsy showed cholestasis pattern with 
bridging fibrosis suggestive of metabolic liver disease (Fig. 1). 
This narrowed down our diagnosis to PFIC or bile acid synthetic 
defects. Further, immunohistochemistry (IHC) depicted the 
absence of canalicular staining consistent with BSEP deficiency. 
Fibro scan showed median of 16.3 Kpa suggestive of significant 
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fibrosis. MCT-based diet with ursodeoxycholic acid (UDCA) was 
prescribed. He was immunized for Hepatitis B and discharged 
in stable condition without any signs of decompensation. 
Parents were counseled for the need of liver transplantation as 
the definitive treatment. At 2-month follow-up showed increase 
in weight, decrease in pruritus, and no evidence of vitamin 
deficiency. Total bilirubin was 1.4 mg/dl with INR-1 and serum 
albumin-3.8 g/dl.
Case 2
A 10-month-old female child born of non-consanguineous 
marriage with uneventful post-natal course presented with 
pruritus for 3 months, bluish patches over the body for 45 days 
and yellowish discoloration of eyes and urine for 15 days. She 
also had an episode of melena 1 month back. There was no 
history of clay-colored stools, steatorrhea, abdominal distension, 
or drug intake. Child was being managed on outpatient basis and 
had received injection Vitamin K and antihistaminic for pruritus. 
There was no past or family history of jaundice.
On examination, her height and weight were between −2 and 
−3 Z score indicating failure to thrive. Pallor and icterus along 
with scratch marks were present. There were no signs of liver 
cell failure or rickets. Firm non-tender hepatomegaly 3 cm below 
costal margin (Span-7.5 cm) with firm splenomegaly of 2 cm was 
present. Rest of the systemic examination was normal. Clinical 
possibility of PFIC 1 or 2, Alagille syndrome and secondary 
sclerosing cholangitis were considered. Her liver function test 
showed a total bilirubin of 2.6 mg/dl (direct fraction: 2 mg/dl). 
Serum glutamic oxaloacetic transaminase/serum glutamic pyruvic 
transaminase was 86/42 IU with GGT of 27 IU which was low. 
She had an albumin of 3.8 g/dl with INR - 1. Complete hemogram 
was suggestive of iron deficiency anemia. Her liver biopsy showed 
distorted acinar architecture, focal bridging fibrosis with cellular, 
and canalicular cholestasis. IHC showed absence of canalicular 
staining confirming BSEP deficiency (Fig. 2). Genetic analysis 
could not be done. Her pruritus was managed with UDCA and 
subsequently rifampicin was added on follow-up. Parents refused 
the option of biliary diversion. Parents were counseled about 
autosomal recessive inheritance and risk in next child.
DISCUSSION
Case 1 is an atypical presentation as there was no pruritus and 
growth failure in the infant despite advanced stage of cholestatic 
liver disease. His presentation simulated viral hepatitis but 
conjunctival xerosis (sign of Vitamin A deficiency) and a firm 
hepatomegaly guided us to investigate for chronic liver disease. This 
could possibly be explained on the basis of genetic polymorphism 
associated with the disease and varied phenotypes [3,4]. Both 
infants showed signs of fat soluble vitamin deficiency. Case 1 
presented with xeropthalmia due to Vitamin A deficiency while 
case 2 had ecchymosis secondary to Vitamin K deficiency. 
Thus, highlighting the need to look for subtle signs of fat soluble 
vitamin deficiencies and treat them early to avoid life-threatening 
complications of coagulopathy and blindness.
In a recent study of 24 PFIC patients in Indian children, a time 
lag of 13 months in diagnosis was seen and familial clustering 
was seen in 12 of 24 cases [5]. Both our cases were first born 
and parents had no history of consanguinity. At 10 months, 
they had advanced fibrosis on liver biopsy. This highlights the 
importance of IHC and GGT in early diagnosis to prevent lethal 
consequences of the disease and improve the outcomes of such 
children. The gold standard for the diagnosis is genetic testing 
using DNA sequencing of the 27 coding exons and their splice 
junctions. Patients with normal BSEP staining should be tested 
for ATP8B1 and with negative BSEP staining should be first 
looked for ABCB11. Genetic analysis in parents may help us in 
prenatal diagnosis [6].
CONCLUSIONS
It is important that diagnosis of PFIC be kept in mind even in 
the absence of disease hallmarks such as jaundice, pruritus, and 
poor growth. Subtle signs of fat soluble vitamin deficiency should 
prompt us to search deeper into the cause. Importance of GGT 
and liver biopsy with IHC cannot be undermined in diagnosing 
rare cases of intrahepatic cholestasis at early stages.
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Figure 1: (a and b) Hematoxylin and eosin stained section of 
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staining in control (b)
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